K
Kristina A. Butler
Researcher at Mayo Clinic
Publications - 46
Citations - 583
Kristina A. Butler is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Ovarian cancer & Cancer. The author has an hindex of 10, co-authored 34 publications receiving 356 citations. Previous affiliations of Kristina A. Butler include University of Insubria.
Papers
More filters
Journal ArticleDOI
Outcomes of Concurrent Breast and Gynecologic Risk Reduction Surgery.
Irene T. Ma,Richard Gray,Nabil Wasif,Kristina A. Butler,Jeffrey L. Cornella,Javier F. Magrina,Paul M. Magtibay,William J. Casey,Raman C. Mahabir,Alanna M. Rebecca,Katherine S. Hunt,Barbara A. Pockaj +11 more
TL;DR: Combined breast and gynecologic procedures for a breast cancer diagnosis and/or risk reduction in patients can be accomplished with acceptable morbidity and Concurrent operations, including reconstruction, can be offered to patients without negatively impacting their outcome.
Journal ArticleDOI
Implementing robotic surgery for uterine cancer in the United States: Better outcomes without increased costs
Jvan Casarin,Jvan Casarin,Chao Song,Francesco Multinu,Serena Cappuccio,E Liu,Kristina A. Butler,Gretchen E. Glaser,William A. Cliby,Carrie L. Langstraat,Fabio Ghezzi,Alex Z. Fu,Andrea Mariani +12 more
TL;DR: Robotic-assisted surgery facilitated the widespread diffusion of a minimally invasive approach nationally for endometrial cancer, with reduction of perioperative morbidity and no increase in overall treatment-related 30-day costs at national level.
Journal ArticleDOI
Results of a phase 2 trial of ribociclib and letrozole in patients with either relapsed estrogen receptor (ER)-positive ovarian cancers or relapsed ER-positive endometrial cancers.
Gerardo Colon-Otero,S. John Weroha,Valentina Zanfagnin,Nathan R. Foster,Erik Asmus,Andrea E. Wahner Hendrickson,Aminah Jatoi,Matthew S. Block,Carrie L. Langstraat,Gretchen E. Glaser,Tri A. Dinh,Matthew W. Robertson,John K. Camoriano,Kristina A. Butler,John A. Copland +14 more
TL;DR: The once-weekly dosing schedule for single agent aromatase inhibitor therapy with or without chemotherapy for ovarian cancer and endometrial cancers was found to be safe and effective.
Journal ArticleDOI
Borderline epithelial ovarian tumors: what the radiologist should know
Kristina T. Flicek,Wendaline M. VanBuren,Kika M. Dudiak,Y Lahkman,L W Chen,Kristina A. Butler,Christine O. Menias +6 more
TL;DR: The sonographic, CT, and MRI features of borderline epithelial ovarian tumors with histopathologic correlation are reviewed to show how these tumors can present in younger patients and may benefit from different clinical/surgical management.
Journal ArticleDOI
Management and outcomes of primary vaginal Cancer.
Jie Yang,Jie Yang,Ritchie Delara,Javier F. Magrina,Paul M. Magtibay,Carrie L. Langstraat,Tri A. Dinh,Nina J. Karlin,Sujay A. Vora,Kristina A. Butler +9 more
TL;DR: Surgery or radiation is effective treatment for vaginal cancer stage I and II and the addition of brachytherapy to external pelvic radiation increases survival in stages III-IV, according to retrospective analysis of patients identified from the Mayo Clinic Cancer Registry.